REVB today
$4.18+$0.23 (+5.96%)close Nov 11, 2026Trend
DailyDowntrend (confirmed)
4 hourLeaning Bullish
1 hourStrong Bullish
15 minLeaning Bearish
5 minStrong Bullish
Daily trend turns up above $1.23
Key levels
Resistance$9.04
Resistance$4.75
Support$3.43
Support$1.10
Latest news & SEC filings
EarningsRevelation Biosciences Posts Q3 2026 Earnings
EarningsRevelation Biosciences posts smaller quarterly loss than expected
SEC FilingRevelation Biosciences, Inc. filed a report on a major company event (Form 8-K)
EarningsRevelation Biosciences to report Q3 2026 financial results
All REVB news →About Revelation Biosciences
Revelation Biosciences develops treatments aimed at restoring balance to the body's inflammatory response. Its main candidate, Gemini, is built on a synthetic TLR4 agonist called PHAD and is being studied for kidney conditions including acute kidney injury and chronic kidney disease. The company is headquartered in San Diego, California, and its shares trade on Nasdaq.
Based on the company's 10-K filed Feb 26, 2026.
Nasdaq · Healthcare
REVELATION BIOSCIENCES, INC. (REVB)
What Is the Price Target for REVB?
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Is REVB a Buy or Sell Right Now?
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for REVB.
Start Free Trial →Is REVB Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
PEG
Fair Value
$-10.00
10
Moat Score
NONE
4/9
Piotroski Score
-7.1
Altman Z-Score
What Is Smart Money Doing with REVB?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →REVB Growth Story
Revenue YoY
N/A%
3yr Revenue CAGR
N/A%
EPS Growth YoY
97.72%
FCF Growth YoY
N/A%
Revenue Trend
UNKNOWN
Dark Pool Trades for REVB
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for REVB, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 16:44:41 | $3.97 | 1,115 | $$4K | SELL |
| 14:49:06 | $3.88 | 1,000 | $$4K | MIDPOINT |
| 14:48:49 | $3.88 | 1,000 | $$4K | BUY |
| 14:48:39 | $3.58 | 1,000 | $$4K | SELL |
| 14:32:44 | $3.92 | 1,000 | $$4K | SELL |
5 dark pool trades shown · $$20K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for REVELATION BIOSCIENCES, INC. (REVB) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →REVB — frequently asked questions
What is REVB stock price today?
REVELATION BIOSCIENCES, INC. (REVB) is at $4.18, up 5.96% (+$0.23) at the Nov 11, 2026 close.
Why is REVB stock moving today?
Latest REVB news — Nov 6, 2026: Revelation Biosciences Posts Q3 2026 Earnings · Nov 5, 2026: Revelation Biosciences posts smaller quarterly loss than expected
Why did REVB stock move on Oct 16, 2026?
Revelation Biosciences (REVB) shares plunged 31.25% today, closing at $0.48 after opening at $0.70, following the company's announcement of a 1-for-7 reverse stock split effective October 20. The stock traded between a high of $0.70 and a low of $0.47 on volume of 569,935 shares.
Did REVB beat earnings?
REVB last reported on Aug 6, 2026: EPS -$0.87 vs -$0.88 expected — a beat of 0.6%.
What is REVB's P/E ratio?
REVB trades at a P/E of 0.1 vs a Healthcare average of 17.9.
Does REVB pay a dividend?
Yes. REVB's dividend yield is 29958.96%.
What are REVB support and resistance levels?
Support: $3.43, $1.10, $0.47. Resistance: $4.75, $9.04, $11.72.
What are insiders doing with REVB?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on REVB?
Nov 6, 2026: Revelation Biosciences Posts Q3 2026 Earnings · Nov 5, 2026: Revelation Biosciences posts smaller quarterly loss than expected · Nov 5, 2026: Revelation Biosciences, Inc. filed a report on a major company event (Form 8-K)